Tumor-associated NADH oxidase (tNOX) is a growth-related protein expressed in transformed cells. tNOX knockdown using RNA interference leads to a significant reduction in HeLa cell proliferation and migration, indicating an important role for tNOX in growth regulation and the cancer phenotype. Here, we show that tNOX is down-regulated during apoptosis in HCT116 cells. Treatment with diverse stresses induced a dose- and time-dependent decrease in tNOX expression that was concurrent with apoptosis. Moreover, shRNA-mediated tNOX knockdown rendered cells susceptible to apoptosis, whereas re-expression of tNOX partially recovered cell proliferation. Our results indicate that tNOX is suppressed during apoptosis and demonstrate that tNOX down-regulation sensitizes cells to stress-induced growth reduction, suggesting that tNOX is required for transformed cell growth.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.febslet.2008.09.008DOI Listing

Publication Analysis

Top Keywords

tnox
10
tumor-associated nadh
8
nadh oxidase
8
transformed cells
8
tnox knockdown
8
cell proliferation
8
apoptosis
5
cells
5
stress-induced down-regulation
4
down-regulation tumor-associated
4

Similar Publications

Lithium metal battery with high specific energy and high safety is crucial for the next-generation energy storage technologies. However, the poor thermal stability, lower mechanical performance, and poor electrochemical performance of the commercially available polyethylene (PE) separator hinders the development of high-specific lithium metal batteries. Herein, a functional PE separator is prepared by innovative coating the TiNbO microspheres with oxygen vacancies on the surface of PE (denoted as TNO-PE).

View Article and Find Full Text PDF

With an increasing incidence of malignant melanoma, new prognostic biomarkers for clinical decision making have become more important. In this study, we evaluated the role of ecto-NOX disulfide-thiol exchanger 2 (ENOX2/tNOX), a cancer- and growth-associated protein, in the prognosis and therapy of primary malignant melanoma. We conducted a tissue microarray analysis of immunohistochemical ENOX2 protein expression and The Cancer Genome Atlas (TCGA) RNA expression analysis, as well as viability assays and Western blots of melanoma cell lines treated with the ENOX2 inhibitor phenoxodiol (PXD) and BRAF inhibitor (BRAFi) vemurafenib.

View Article and Find Full Text PDF

High areal capacity and low-temperature ability are critical for lithium-ion batteries (LIBs). However, the practical operation is seriously impeded by the sluggish rates of mass and charge transfer. Herein, the active electronic states of TiNbO material is modulated by dopant and O-vacancies for enhanced low-temperature dynamics.

View Article and Find Full Text PDF

The antibiotic heliomycin (resistomycin), which is generated from , has multiple activities, including anticancer effects. Heliomycin was first described in the 1960s, but its clinical applications have been hindered by extremely low solubility. A series of 4-aminomethyl derivatives of heliomycin were synthesized to increase water solubility; studies showed that they had anti-proliferative effects, but the drug targets remained unknown.

View Article and Find Full Text PDF

Capsaicinoids and Their Effects on Cancer: The "Double-Edged Sword" Postulate from the Molecular Scale.

Cells

November 2023

Laboratorio de Biología Celular y Molecular, Facultad de Ciencias Naturales, Universidad Autónoma de Querétaro, Av. De las Ciencias s/n, Juriquilla, Querétaro 76230, Querétaro, Mexico.

Capsaicinoids are a unique chemical species resulting from a particular biosynthesis pathway of hot chilies ( spp.) that gives rise to 22 analogous compounds, all of which are TRPV1 agonists and, therefore, responsible for the pungency of fruits. In addition to their human consumption, numerous ethnopharmacological uses of chili have emerged throughout history.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!